Live Breaking News & Updates on Cns Pharmaceuticals Inc

Stay updated with breaking news from Cns pharmaceuticals inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) Short Interest Update

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP – Get Rating) was the recipient of a large increase in short interest during the month of March. As of March 15th, there was short interest totalling 24,500 shares, an increase of 49.4% from the February 28th total of 16,400 shares. Approximately 2.3% of the shares of the stock are short […] ....

Pharmaceuticals-stock , Cns-pharmaceuticals-inc , Nasdaq , Virtu-financial , Renaissance-technologies , Pharmaceuticals-inc , Pharmaceuticals-daily , Armistice-capital , York-mellon-corp , Get-rating , New-york-mellon-corp

Short Interest in CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) Expands By 49.4%

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP – Get Rating) was the target of a significant growth in short interest during the month of March. As of March 15th, there was short interest totalling 24,500 shares, a growth of 49.4% from the February 28th total of 16,400 shares. Based on an average trading volume of 42,400 shares, the […] ....

York-mellon-corp , Virtu-financial , Pharmaceuticals-daily , Cns-pharmaceuticals-inc , Armistice-capital , Renaissance-technologies , Nasdaq , Pharmaceuticals-inc , Pharmaceuticals-stock , Get-rating , New-york-mellon-corp

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) Short Interest Update

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP – Get Rating) was the target of a large increase in short interest in the month of May. As of May 31st, there was short interest totalling 528,500 shares, an increase of 80.6% from the May 15th total of 292,600 shares. Based on an average trading volume of 854,300 shares, the […] ....

Virtu-financial , Renaissance-technologies , Nasdaq , Pharmaceuticals-company-profile-get-rating , York-mellon-corp , Maxim-group , Cns-pharmaceuticals-inc , Pharmaceuticals-inc , Citadel-advisors , Get-rating , Street-corp

Short Interest in CNS Pharmaceuticals, Inc. (NASDAQ:CNSP) Declines By 46.3%

CNS Pharmaceuticals, Inc. (NASDAQ:CNSP – Get Rating) saw a significant decline in short interest in the month of March. As of March 15th, there was short interest totalling 291,000 shares, a decline of 46.3% from the February 28th total of 541,900 shares. Currently, 1.6% of the shares of the company are short sold. Based on […] ....

Geode-capital-management , Zacks-investment-research , Renaissance-technologies , Nasdaq , Pharmaceuticals-get-rating , York-mellon-corp , Cns-pharmaceuticals-inc , Pharmaceuticals-inc , Citadel-advisors , Get-rating , Street-corp